Sen. Jim Banks (R-Ind.) wants the Food and Drug Administration (FDA) to look into foreign-made active pharmaceutical ...

Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Xeris ...

Flavonoids show promise in treating type 2 diabetes mellitus by targeting the enteroendocrine system and regulating key gut ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

Studies show that high-protein diets can help GLP-1 (glucagon-like peptide 1) medication users be more successful in their weight loss efforts. Glynn Tonsor, an ag economist with Kansas State ...

Scientists at Pennington Biomedical Research Center have gained greater clarity in the brain regions and neurons that control ...

Liraglutide is a peptide that has gained significant attention in scientific research due to its structural similarity to ...

President Donald Trump continues to warn of tariffs on the pharmaceutical industry; Susan Monarez replaces Dave Weldon as CDC ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity ...

The United Laboratories International Holdings Limited and Novo Nordisk (NVO) announced earlier that Novo Nordisk and TUL’s wholly-owned ...